long intergenic non-protein coding RNA 1953Genealiases: []
Q-omics provides the consensus-scored LINC01953 profile across patient tissues and cancer cell-line models. LINC01953 expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in UCEC. Among the 18 cancer types available for tumor–normal comparison, LINC01953 is differentially expressed in 1, with the highest sampling consensus in BRCA. Additionally, LINC01953 RNA expression shows 5,852 significant gene co-expression associations, with the highest sampling consensus in COAD. Together, these results highlight UCEC, BRCA, and COAD as cancer lineages where LINC01953 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01953 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01953 survival associations across molecular data types. LINC01953 RNA expression shows survival associations in the most cancer types (13). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01953 RNA expression–survival associations across cancer types. High LINC01953 expression shows unfavorable associations in UCEC, KICH, THYM, CHOL, OV and TGCT. The UCEC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCEC as the clearest survival context for LINC01953 RNA expression.
This table summarizes LINC01953 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in BRCA for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01953. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01953 shows higher tumor expression in BRCA. The BRCA box plot shows higher LINC01953 RNA expression in tumor versus normal tissue (log2 FC = +0.126, t-test p < 0.001).
This table shows molecular features associated with LINC01953 in patient tissues and cancer cell lines. In patient samples, LINC01953 shows the broadest associations at the RNA and protein expression levels, with COAD recurring as the lineage with the largest associated feature set.
